Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 1323

1.

Transcriptional Network Analysis Implicates Altered Hepatic Immune Function in NASH development and resolution.

Haas JT, Vonghia L, Mogilenko DA, Verrijken A, Molendi-Coste O, Fleury S, Deprince A, Nikitin A, Woitrain E, Ducrocq-Geoffroy L, Pic S, Derudas B, Dehondt H, Gheeraert C, Van Gaal L, Driessen A, Lefebvre P, Staels B, Francque S, Dombrowicz D.

Nat Metab. 2019 Jun;1(6):604-614. doi: 10.1038/s42255-019-0076-1. Epub 2019 Jun 14.

PMID:
31701087
2.

Comparison of Time to Next Treatment, Health Care Resource Utilization, and Costs in Patients with Chronic Lymphocytic Leukemia Initiated on Front-line Ibrutinib or Chemoimmunotherapy.

Emond B, Sundaram M, Romdhani H, Lefebvre P, Wang S, Mato A.

Clin Lymphoma Myeloma Leuk. 2019 Aug 26. pii: S2152-2650(19)31321-7. doi: 10.1016/j.clml.2019.08.004. [Epub ahead of print]

3.

Experimental redox transformations of uranium phosphate minerals and mononuclear species in a contaminated wetland.

Stetten L, Lefebvre P, Le Pape P, Mangeret A, Blanchart P, Merrot P, Brest J, Julien A, Bargar JR, Cazala C, Morin G.

J Hazard Mater. 2019 Oct 3;384:121362. doi: 10.1016/j.jhazmat.2019.121362. [Epub ahead of print]

PMID:
31634806
4.

Development of risk models for major adverse chronic renal outcomes among patients with type 2 diabetes mellitus using insurance claims: a retrospective observational study.

Wysham CH, Gauthier-Loiselle M, Bailey RA, Manceur AM, Lefebvre P, Greenberg M, Duh MS, Young JB.

Curr Med Res Opin. 2019 Nov 6:1-9. doi: 10.1080/03007995.2019.1682981. [Epub ahead of print]

PMID:
31625766
5.

Burden of treatment-resistant depression in Medicare: A retrospective claims database analysis.

Pilon D, Joshi K, Sheehan JJ, Zichlin ML, Zuckerman P, Lefebvre P, Greenberg PE.

PLoS One. 2019 Oct 10;14(10):e0223255. doi: 10.1371/journal.pone.0223255. eCollection 2019.

6.

Structural differences in eating disorder psychopathology after history of childhood abuse: Insights from a Bayesian network analysis.

Rodgers RF, DuBois R, Thiebaut S, Jaussent I, Maimoun L, Seneque M, Lefebvre P, Renard E, Courtet P, Guillaume S.

J Abnorm Psychol. 2019 Nov;128(8):795-805. doi: 10.1037/abn0000470. Epub 2019 Oct 10.

PMID:
31599631
7.

Are Medicaid Coverage Gaps Associated with Higher Health Care Resource Utilization and Costs in Patients with Schizophrenia?

Pilon D, El Khoury AC, Manceur AM, Zhdanava M, Benson C, Lefebvre P, Doshi JA.

Popul Health Manag. 2019 Oct 8. doi: 10.1089/pop.2019.0147. [Epub ahead of print]

PMID:
31592717
8.

Retrospective Study on the Association of Biomarkers With Real-world Outcomes of Omalizumab-treated Patients With Allergic Asthma.

Kavati A, Zhdanava M, Ortiz B, Lecocq J, Schiffman B, Pilon D, Ho H, Lefebvre P, Stone B.

Clin Ther. 2019 Oct;41(10):1956-1971. doi: 10.1016/j.clinthera.2019.07.021. Epub 2019 Sep 25.

9.

Adherence to heart failure management medications following cardiac resynchronization therapy.

Shah BR, DerSarkissian M, Tsintzos SI, Xiao Y, May D, Lu X, Kinrich D, Davis E, Lefebvre P, Duh MS, Dasta JF.

Curr Med Res Opin. 2019 Oct 7:1-9. doi: 10.1080/03007995.2019.1670474. [Epub ahead of print]

PMID:
31535559
10.

Auditory function and dysfunction: estrogen makes a difference.

Delhez A, Lefebvre P, Péqueux C, Malgrange B, Delacroix L.

Cell Mol Life Sci. 2019 Sep 14. doi: 10.1007/s00018-019-03295-y. [Epub ahead of print] Review.

PMID:
31522250
11.

Acute and longer-term body composition changes after bariatric surgery.

Maïmoun L, Lefebvre P, Aouinti S, Picot MC, Mariano-Goulart D, Nocca D; Montpellier Study Group of Bariatric Surgery.

Surg Obes Relat Dis. 2019 Jul 29. pii: S1550-7289(19)30329-6. doi: 10.1016/j.soard.2019.07.006. [Epub ahead of print]

PMID:
31519485
12.

Nickel and iron partitioning between clay minerals, Fe-oxides and Fe-sulfides in lagoon sediments from New Caledonia.

Merrot P, Juillot F, Noël V, Lefebvre P, Brest J, Menguy N, Guigner JM, Blondeau M, Viollier E, Fernandez JM, Moreton B, Bargar JR, Morin G.

Sci Total Environ. 2019 Nov 1;689:1212-1227. doi: 10.1016/j.scitotenv.2019.06.274. Epub 2019 Jun 21.

PMID:
31466160
13.

Long-term omalizumab outcomes in chronic idiopathic urticaria: a real-world study.

Kavati A, Zhdanava M, Ortiz B, LeCocq J, Schiffman B, Pilon D, Ching Cheung H, Lefebvre P, Stone BD.

Allergy Asthma Proc. 2019 Sep 1;40(5):321-328. doi: 10.2500/aap.2019.40.4236. Epub 2019 Jul 25.

PMID:
31345280
14.

Water-in-PDMS Emulsion Templating of Highly Interconnected Porous Architectures for 3D Cell Culture.

Riesco R, Boyer L, Blosse S, Lefebvre PM, Assemat P, Leichle T, Accardo A, Malaquin L.

ACS Appl Mater Interfaces. 2019 Aug 14;11(32):28631-28640. doi: 10.1021/acsami.9b07564. Epub 2019 Aug 2.

PMID:
31334634
15.

Temporal processing properties of auditory DUM neurons in a bush-cricket.

Stumpner A, Lefebvre PC, Seifert M, Ostrowski TD.

J Comp Physiol A Neuroethol Sens Neural Behav Physiol. 2019 Oct;205(5):717-733. doi: 10.1007/s00359-019-01359-9. Epub 2019 Jul 20.

PMID:
31327050
16.

US Integrated Delivery Networks Perspective on Economic Burden of Patients with Treatment-Resistant Depression: A Retrospective Matched-Cohort Study.

Pilon D, Szukis H, Joshi K, Singer D, Sheehan JJ, Wu JW, Lefebvre P, Greenberg P.

Pharmacoecon Open. 2019 Jun 28. doi: 10.1007/s41669-019-0154-z. [Epub ahead of print]

17.

Trapping Dipolar Exciton Fluids in GaN/(AlGa)N Nanostructures.

Chiaruttini F, Guillet T, Brimont C, Jouault B, Lefebvre P, Vives J, Chenot S, Cordier Y, Damilano B, Vladimirova M.

Nano Lett. 2019 Aug 14;19(8):4911-4918. doi: 10.1021/acs.nanolett.9b00914. Epub 2019 Jul 3.

PMID:
31241962
18.

Responsiveness of acoustic rhinometry to septorhinoplasty by comparison with rhinomanometry and subjective instruments.

Ansari E, Rogister F, Lefebvre P, Tombu S, Poirrier AL.

Clin Otolaryngol. 2019 Sep;44(5):778-783. doi: 10.1111/coa.13394. Epub 2019 Jul 7.

PMID:
31220404
19.

[Alcohol consumption and head and neck cancer].

Goffinet M, Ransy P, Bouchain O, Lefebvre P, Moreau P.

Rev Med Liege. 2019 May;74(5-6):349-353. French.

20.

Hepatic transcriptomic signatures of statin treatment are associated with impaired glucose homeostasis in severely obese patients.

Margerie D, Lefebvre P, Raverdy V, Schwahn U, Ruetten H, Larsen P, Duhamel A, Labreuche J, Thuillier D, Derudas B, Gheeraert C, Dehondt H, Dhalluin Q, Alexandre J, Caiazzo R, Nesslany P, Verkindt H, Pattou F, Staels B.

BMC Med Genomics. 2019 Jun 3;12(1):80. doi: 10.1186/s12920-019-0536-1.

21.

Is clinician impression of depression symptom severity associated with incremental economic burden in privately insured US patients with treatment resistant depression?

Pilon D, Sheehan JJ, Szukis H, Morrison L, Zhdanava M, Lefebvre P, Joshi K.

J Affect Disord. 2019 Aug 1;255:50-59. doi: 10.1016/j.jad.2019.04.100. Epub 2019 May 1.

22.

Healthcare resource utilization and costs associated with venous thromboembolism in cancer patients treated with anticoagulants.

Streiff M, Milentijevic D, McCrae KR, Laliberté F, Lejeune D, Lefebvre P, Schein J, Khorana AA.

J Med Econ. 2019 Nov;22(11):1134-1140. doi: 10.1080/13696998.2019.1620752. Epub 2019 Jun 12.

PMID:
31106638
23.

Real-world incidence of inflammatory bowel disease among patients with other chronic inflammatory diseases treated with interleukin-17a or phosphodiesterase 4 inhibitors.

Emond B, Ellis LA, Chakravarty SD, Ladouceur M, Lefebvre P.

Curr Med Res Opin. 2019 Oct;35(10):1751-1759. doi: 10.1080/03007995.2019.1620713. Epub 2019 Jun 6.

PMID:
31106607
24.

The effect of excessive fat tissue on the measure of bone mineral density by dual X-ray absorptiometry: the impact of substantial weight loss following sleeve gastrectomy.

Maïmoun L, Mariano-Goulart D, Jaussent A, Lefebvre P, Picot MC, Mahadea K, Boudousq V, Fouillade C, Nocca D, Ben Bouallègue F.

Clin Physiol Funct Imaging. 2019 Sep;39(5):345-354. doi: 10.1111/cpf.12584. Epub 2019 Jul 24.

PMID:
31090241
25.

A screening tool for psychological difficulties in children aged 6 to 36 months: cross-cultural validation in Kenya, Cambodia and Uganda.

Nackers F, Roederer T, Marquer C, Ashaba S, Maling S, Mwanga-Amumpaire J, Muny S, Sokeo C, Shom V, Palha M, Lefèbvre P, Kirubi BW, Kamidigo G, Falissard B, Moro MR, Grais RF.

BMC Pediatr. 2019 Apr 12;19(1):108. doi: 10.1186/s12887-019-1461-3.

26.

Hepatocyte-specific loss of GPS2 in mice reduces non-alcoholic steatohepatitis via activation of PPARα.

Liang N, Damdimopoulos A, Goñi S, Huang Z, Vedin LL, Jakobsson T, Giudici M, Ahmed O, Pedrelli M, Barilla S, Alzaid F, Mendoza A, Schröder T, Kuiper R, Parini P, Hollenberg A, Lefebvre P, Francque S, Van Gaal L, Staels B, Venteclef N, Treuter E, Fan R.

Nat Commun. 2019 Apr 11;10(1):1684. doi: 10.1038/s41467-019-09524-z.

27.

Economic Burden and Health-Related Quality of Life Associated with Current Treatments for Anaemia in Patients with CKD not on Dialysis: A Systematic Review.

Pergola PE, Pecoits-Filho R, Winkelmayer WC, Spinowitz B, Rochette S, Thompson-Leduc P, Lefebvre P, Shafai G, Bozas A, Sanon M, Krasa HB.

Pharmacoecon Open. 2019 Apr 9. doi: 10.1007/s41669-019-0132-5. [Epub ahead of print] Review.

28.

Real-world impact of glycated hemoglobin reduction on treatment intensification and glycated hemoglobin goal attainment in type 2 diabetes mellitus patients initiated on a sodium glucose co-transporter 2 (SGLT2) inhibitor (SGLT2i).

Brunton S, Rozjabek HM, Pilon D, Lafeuille MH, Kamstra R, Wynant W, Bookhart BK, Lefebvre P.

Curr Med Res Opin. 2019 Apr 9:1-8. doi: 10.1080/03007995.2019.1605160. [Epub ahead of print]

PMID:
30964362
29.

Healthcare costs of stroke and major bleeding in patients with atrial fibrillation treated with non-vitamin K antagonist oral anticoagulants.

Rozjabek HM, Coleman CI, Ashton V, Laliberté F, Oyefesobi P, Lejeune D, Germain G, Schein JR, Yuan Z, Lefebvre P, Peterson ED.

J Med Econ. 2019 Aug;22(8):751-759. doi: 10.1080/13696998.2019.1603156. Epub 2019 Apr 25.

PMID:
30939954
30.

Oral contraceptives partially protect from bone loss in young women with anorexia nervosa.

Maïmoun L, Renard E, Lefebvre P, Bertet H, Philibert P, Seneque M, Picot MC, Dupuy AM, Gaspari L, Ben Bouallègue F, Courtet P, Mariano-Goulart D, Sultan C, Guillaume S.

Fertil Steril. 2019 May;111(5):1020-1029.e2. doi: 10.1016/j.fertnstert.2019.01.008. Epub 2019 Mar 25.

PMID:
30922647
31.

Spontaneous Coronary Artery Dissection in the Postoperative Period: A Case Report.

Bendinelli V, Lefebvre P, Daper A.

A A Pract. 2019 Aug 1;13(3):99-101. doi: 10.1213/XAA.0000000000001003.

PMID:
30907753
32.

A genome-wide algal mutant library and functional screen identifies genes required for eukaryotic photosynthesis.

Li X, Patena W, Fauser F, Jinkerson RE, Saroussi S, Meyer MT, Ivanova N, Robertson JM, Yue R, Zhang R, Vilarrasa-Blasi J, Wittkopp TM, Ramundo S, Blum SR, Goh A, Laudon M, Srikumar T, Lefebvre PA, Grossman AR, Jonikas MC.

Nat Genet. 2019 Apr;51(4):627-635. doi: 10.1038/s41588-019-0370-6. Epub 2019 Mar 18.

33.

Economic and quality of life burden of anemia on patients with CKD on dialysis: a systematic review.

Spinowitz B, Pecoits-Filho R, Winkelmayer WC, Pergola PE, Rochette S, Thompson-Leduc P, Lefebvre P, Shafai G, Bozas A, Sanon M, Krasa HB.

J Med Econ. 2019 Jun;22(6):593-604. doi: 10.1080/13696998.2019.1588738. Epub 2019 Mar 27.

PMID:
30813807
34.

Isotopic Fingerprint of Uranium Accumulation and Redox Cycling in Floodplains of the Upper Colorado River Basin.

Lefebvre P, Noël V, Lau KV, Jemison NE, Weaver KL, Williams KH, Bargar JR, Maher K.

Environ Sci Technol. 2019 Apr 2;53(7):3399-3409. doi: 10.1021/acs.est.8b05593. Epub 2019 Mar 12.

PMID:
30807121
35.

Impact of bipolar disorder on eating disorders severity in real-life settings.

Thiebaut S, Jaussent I, Maimoun L, Beziat S, Seneque M, Hamroun D, Lefebvre P, Godart N, Renard E, Courtet P, Guillaume S.

J Affect Disord. 2019 Mar 1;246:867-872. doi: 10.1016/j.jad.2018.12.128. Epub 2018 Dec 26.

PMID:
30795493
36.

Intratympanic steroid therapy for refractory sudden sensory hearing loss: a 12-year experience with the Silverstein catheter.

Vanwijck F, Rogister F, Pierre Barriat S, Camby S, Lefebvre P.

Acta Otolaryngol. 2019 Feb;139(2):111-116. doi: 10.1080/00016489.2018.1532107. Epub 2019 Feb 22.

PMID:
30794063
37.

Medicaid spending burden among beneficiaries with treatment-resistant depression.

Pilon D, Sheehan JJ, Szukis H, Singer D, Jacques P, Lejeune D, Lefebvre P, Greenberg PE.

J Comp Eff Res. 2019 Apr;8(6):381-392. doi: 10.2217/cer-2018-0140. Epub 2019 Feb 8.

38.

Duration of anticoagulant therapy and VTE recurrence in patients with cancer.

Khorana AA, McCrae KR, Milentijevic D, Fortier J, Nelson WW, Laliberté F, Crivera C, Lefebvre P, Schein J.

Support Care Cancer. 2019 Oct;27(10):3833-3840. doi: 10.1007/s00520-019-4661-3. Epub 2019 Feb 8.

39.

Consideration of Potential Drug-Drug Interactions in Selection of FDA-Approved Drugs Indicated for Prostate Cancer.

Pilon D, Ellis LA, Xiao Y, Behl AS, Lefebvre P.

Am J Ther. 2019 May/Jun;26(3):e422-e424. doi: 10.1097/MJT.0000000000000693. No abstract available.

PMID:
30677005
40.

Comment on "The price of abandoning diagnostics testing for cell-free fetal DNA screening".

Skotko BG, Samuelson D, Kageleiry A, Lefebvre P, Hellstern M, Campbell J.

Prenat Diagn. 2019 Jan;39(2):130. doi: 10.1002/pd.5331. Epub 2019 Jan 13. No abstract available.

PMID:
30637775
41.

Ejection fraction, B-type natriuretic peptide and risk of stroke and acute myocardial infarction among patients with heart failure.

Greenberg B, Peterson ED, Berger JS, Laliberté F, Zhao Q, Germain G, Lejeune D, Wu JW, Lefebvre P, Fonarow GC.

Clin Cardiol. 2019 Feb;42(2):277-284. doi: 10.1002/clc.23140. Epub 2019 Jan 7.

42.

Economic modelling of costs associated with outcomes reported for type 2 diabetes mellitus (T2DM) patients in the CANVAS and EMPA-REG cardiovascular outcomes trials.

Kamstra R, Durkin M, Cai J, Bookhart B, Lafeuille MH, Pilon D, Tiggelaar S, Manceur AM, Lefebvre P.

J Med Econ. 2019 Mar;22(3):280-287. doi: 10.1080/13696998.2018.1562817. Epub 2019 Jan 11.

PMID:
30575426
43.

Real-world outcomes post-transition to once-every-3-months paliperidone palmitate in patients with schizophrenia within US commercial plans.

Emond B, El Khoury AC, Patel C, Pilon D, Morrison L, Zhdanava M, Lefebvre P, Tandon N, Joshi K.

Curr Med Res Opin. 2019 Mar;35(3):407-416. doi: 10.1080/03007995.2018.1560220. Epub 2019 Jan 5.

PMID:
30556739
44.

An investigation into the durability of glycemic control in patients with type II diabetes initiated on canagliflozin or sitagliptin: A real-world analysis of electronic medical records.

Wysham CH, Lefebvre P, Pilon D, Lafeuille MH, Emond B, Kamstra R, Pfeifer M, Duh MS, Ingham M.

J Diabetes Complications. 2019 Feb;33(2):140-147. doi: 10.1016/j.jdiacomp.2018.10.016. Epub 2018 Oct 31.

45.

The economic burden of psoriasis with high comorbidity among privately insured patients in the United States.

Pilon D, Teeple A, Zhdanava M, Ladouceur M, Ching Cheung H, Muser E, Lefebvre P.

J Med Econ. 2019 Feb;22(2):196-203. doi: 10.1080/13696998.2018.1557201. Epub 2019 Jan 3.

PMID:
30523738
46.

The prospective economic impact of once monthly paliperidone palmitate versus oral atypical antipsychotics in Medicaid patients with schizophrenia.

El Khoury AC, Pilon D, Morrison L, Shak N, Vermette-Laforme M, Amos TB, Kim E, Lefebvre P.

Curr Med Res Opin. 2019 Mar;35(3):395-405. doi: 10.1080/03007995.2018.1558195. Epub 2019 Jan 3.

PMID:
30526125
47.

The risk of recurrent VTE and major bleeding in a commercially-insured population of cancer patients treated with anticoagulation.

Khorana AA, McCrae K, Milentijevic D, McCormick N, Laliberté F, Crivera C, Lefebvre P, Lejeune D, Rozjabek H, Schein J, Streiff MB.

Am J Hematol. 2019 Feb;94(2):E58-E61. doi: 10.1002/ajh.25361. Epub 2018 Dec 18. No abstract available.

48.

[Reappraisal of metformin : less restrictions and more potential indications].

Scheen AJ, Lefèbvre PJ, Paquot N.

Rev Med Liege. 2018 Nov;73(11):544-549. French.

49.

Combinatorial regulation of hepatic cytoplasmic signaling and nuclear transcriptional events by the OGT/REV-ERBα complex.

Berthier A, Vinod M, Porez G, Steenackers A, Alexandre J, Yamakawa N, Gheeraert C, Ploton M, Maréchal X, Dubois-Chevalier J, Hovasse A, Schaeffer-Reiss C, Cianférani S, Rolando C, Bray F, Duez H, Eeckhoute J, Lefebvre T, Staels B, Lefebvre P.

Proc Natl Acad Sci U S A. 2018 Nov 20;115(47):E11033-E11042. doi: 10.1073/pnas.1805397115. Epub 2018 Nov 5.

50.

Does the route of administration for estrogen hormone therapy impact the risk of venous thromboembolism? Estradiol transdermal system versus oral estrogen-only hormone therapy.

Laliberté F, Dea K, Duh MS, Kahler KH, Rolli M, Lefebvre P.

Menopause. 2018 Nov;25(11):1297-1305. doi: 10.1097/GME.0000000000001232.

PMID:
30358726

Supplemental Content

Loading ...
Support Center